Melanoma With Brain Metastases Benefits From Ipilimumab Medscape The cohort consisted of 51 patients who were neurologically asymptomatic and not receiving corticosteroids at study entry and 21 patients who were symptomatic and on stable doses of corticosteroids. All patients were scheduled to receive 4 doses of ... |
